Overview

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
This study aims to determine the effect of metformin along with standard cancer treatment, and its effect on the prognosis of the metastatic breast in non-diabetic patients.
Phase:
Phase 2
Details
Lead Sponsor:
Hager salah el din
Treatments:
Metformin